DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
DEXTRAN 40
Search structure
Synonyms:
Dextran 40
Gentran 40
LMD
LMWD
Status:
Phase 2
Entry Type:
Oligosaccharide
Molecule Category:
UNKNOWN
UNII:
K3R6ZDH4DU
Indications
Mesh Heading
Maximum Phase
Mesh ID
Reference
Liver Cirrhosis
2
D008103
ClinicalTrials
Related Entries
MCS
3
Analyze Networks
×
Target Level :
Level 3
Level 4
Level 5
Level 6
Extend :
Indication
Mechanism of Action
Primary Target
Target Level
Apply
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA
×
Datasets:
Active Pharmaceutical Ingredients (APIs)
Scaffolds
Search:
SubStructure
Cross References
Resources
Reference
ChEMBL
CHEMBL2109168
FDA SRS
K3R6ZDH4DU
CONTENTS
Structure
Indications
Related Entries
Cross References
×
Active Pharmaceutical Ingredients (APIs)
Scaffolds
Exact
Similarity
SubStructure
Threshold (%) >=
70